Latest News and Press Releases

-Webinar to be held Friday, November 19, 2021 at 11:00 a.m. ET- -Featuring Harriet Kluger, M.D., renowned researcher, medical oncologist and lead investigator in the Phase 2 study of sotigalimab in...

CAMBRIDGE, Mass., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapy company focused on driving innovation to transform outcomes for cancer patients, today...

WOODCLIFF LAKE, N.J., Nov. 09, 2021 (GLOBE NEWSWIRE) -- PowerFleet, Inc. (Nasdaq: PWFL), a global leader and provider of subscription-based wireless IoT and M2M solutions for securing, controlling,...

CAMBRIDGE, Mass., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and...

WINNIPEG, Manitoba, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...

SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de...

AUSTIN, Texas, Nov. 09, 2021 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (“SCV”) today announces the availability of a new interview with Marc Hazout, CEO, SusGlobal Energy Corp. (OTCQB: SNRG)...

 Company to host conference call on Tuesday, November 9 at 8:30 am EST Dose escalation for cell therapy candidate ACTengine® IMA203 ongoing; dose level 3 completed at doses below 1 billion...

New York, Nov. 09, 2021 (GLOBE NEWSWIRE) -- DASH Regulatory Technologies (DRT) – the regtech-focused affiliate of U.S. options technology and execution services provider DASH Financial Technologies...

Press ReleaseStockholm, Sweden, November 9, 2021Immunicum to Present New Research Data at The Society for Immunotherapy of Cancer (SITC) Annual MeetingImmunicum AB (publ; IMMU.ST), a biopharmaceutical...